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Physiologic and pathologic events associated with
cutaneous differentiation and repair are the result of
a concerted action of various types of resident tissue
cells. In vitro models simulating this complex in vivo
situation are therefore needed to clarify the speci®c
contribution and relevant interaction of, for exam-
ple, dermal mast cells with other major cutaneous
cells. The aim of this study was to establish a long-
term coculture model that includes dermal mast
cells, dermal ®broblasts, and keratinocytes in a
human skin equivalent organotypic setting. Normal
dermal mast cells and ®broblasts (1:4) were enclosed
in collagen gel and normal keratinocytes were grown
on top with exposure to the air interface. Under
these conditions, mast cell integrity and functionality
was preserved even after 4 wk of culture, as shown
by electron microscopy and immunohistochemistry
using antibodies against the mast-cell-speci®c gran-
ule enzyme tryptase and the receptors for stem cell
factor and IgE. Mast cells also released histamine on
stimulation with anti-IgE, and on ultrastructure were
found to degranulate, with decrease of granule mat-
rix density and formation of cell±cell contacts with
®broblasts. After 2 wk of culture, keratinocytes had
formed an epidermis-like multilayer and were able
to proliferate and differentiate, as shown by bromo-
deoxyuridine incorporation of basal cells and immu-
nohistochemical staining for transglutaminase and
cytokeratins 1 and 10. The model presented here
thus provides a potentially relevant tool to further
clarify the interaction of dermal mast cells with
major other skin cells and their contribution to cuta-
neous physiology, repair processes, and pathology.
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eratinocytes and ®broblasts represent the best studied
cells in epidermal differentiation and in pathologic
processes such as cutaneous wound healing. Their
proliferation rate and differentiation status is con-
trolled not only by autocrine mechanisms or plasma-
borne factors, but also by paracrine mechanisms through factors
released by adjacent cells. Several examples can be cited for the
interaction of keratinocytes and ®broblasts in this context: e.g.,
interleukin-1 synthesized by keratinocytes induces the synthesis of
®broblast growth factor 7 (FGF-7) (keratinocyte growth factor) in
®broblasts, which in turn promotes keratinocyte differentiation
(Maas-Szabowski et al, 2000). Diverse additional cells normally
residing in close association with keratinocytes and ®broblasts
might also contribute to these processes, however, but have so far
rarely been included in these studies.
Mast cells represent one such additional cell type. They are
ubiquitously distributed throughout all organs, with a striking
predominance in the dermis or lamina propria of epithelial tissues,
in close apposition to vessels, appendages, and nerves. Mast cells are
particularly interesting for interaction studies because they can
generate, store, and release a variety of mediators that have the
potential to act on cell proliferation and differentiation (for further
review see Weber et al, 1995; Metcalfe et al, 1997). Until now, these
cells have been shown to promote ®broblast proliferation and,
conversely, to impede keratinocyte proliferation via their speci®c
mediators tryptase and chymase (Ruoss et al, 1991; Nadel, 1991;
Algermissen et al, 1999). Furthermore, mast cells are able to synthesize
and release various growth factors such as nerve growth factor, stem
cell factor (SCF), platelet-derived growth factor AA and FGF-2,
through which they can in¯uence proliferation and differentiation of
adjacent cells (Metcalfe et al, 1997; Artuc et al, 1999). Recent studies
of our group showed, moreover, that the classical mast cell mediators
histamine and tryptase are able to stimulate the release of certain
growth factors (FGF-2 or FGF-7, respectively) by dermal ®broblasts,
which may offer an additional mechanism to interact with closely
associated cells.1 Still, although several observations have been made
concerning the in¯uence of mast cells on the proliferation rate of
adjoining cells, much less is known about their in¯uence on cell
differentiation, especially of keratinocytes.
We are in particular interested in the latter topic, and for this
purpose, intended to establish an in vitro model for the study of mast
cell±keratinocyte interactions. Our model is based on a well-
established organotypic skin model in which human keratinocytes
are cultured on a collagen gel containing dermal ®broblasts
(Fusenig, 1994). During culture, keratinocytes are exposed to air,
which enables them to differentiate and form an epidermis-like
multilayer.
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In order to study mast cell±keratinocyte interactions, we
additionally embedded freshly isolated, puri®ed dermal mast cells
into the collagen gel. The purpose of the study presented here was
to ®nd out whether the organotypic model is suitable for the long-
term culture of human mast cells, and to de®ne the speci®c culture
conditions required. The integrity and functionality of the cells was
tested based on the following criteria: morphology, degranulation,
and cell±cell contact with ®broblasts (all examined by electron
microscopy), as well as the expression of Kit receptor, the high-
af®nity IgE receptor, and tryptase (all demonstrated by immuno-
histochemistry).
Our data show that the organotypic culture model is suitable for
long-term culture of human dermal mast cells in the absence of
mast cell growth factors required for the long-term viability and
functionality of mast cells, particularly for the clari®cation of their
interaction with ®broblasts and keratinocytes.
MATERIALS AND METHODS
Isolation of human dermal mast cells The source of skin tissue and
the isolation and puri®cation of human dermal mast cells have been
described previously (GruÈtzkau et al, 2000). Brie¯y, the epidermis was
enzymatically detached from the dermis by an overnight incubation with
dispase (Boehringer, Mannheim, Germany) at a concentration of 1 mg
per ml. The dermis was then cut into small pieces and incubated with
collagenase type IV (Worthington Biochem, Freehold) for up to
120 min (dependent on the amount of tissue) at 37°C. Thereafter, cells
were recovered, washed, and cultured overnight in standard conditions
in RPMI 1640 medium (Biochrom, Berlin, Germany) supplemented
with 10% fetal bovine serum (FBS) (Biochrom) in order to allow
®broblasts and endothelial cells to attach. Mast cells were further
enriched by positive magnetic selection using the magnetic cell sorting
microbeads technology (Milteny Biotec, Bergisch Gladbach, Germany).
For that purpose, the dermal cell suspension was incubated for 30 min
with the monoclonal antibody (MoAb) YB5.B8, which recognizes the
Kit receptor (CD 117) (kindly provided by Dr. L. Ashman, Adelaide,
Australia). After washing with phosphate-buffered saline (PBS)
supplemented with 1% bovine serum albumin (BSA) and
ethylenediamine tetraacetic acid (EDTA), a second incubation was done
with a magnetic cell sorting conjugated goat-antimouse polyclonal serum
(Milteny). Labeled cells were separated by passage over a large cell
separation column (Milteny), which was placed in a magnetic ®eld. Cells
were then washed thrice and, after removing the column from the
separator, retained cells were eluted with 500 ml PBS (supplemented
with 1% BSA and EDTA). Purity of mast cells was over 90%, as
measured by ¯ow cytometry. Mast cells were identi®ed by
immunostaining for the c-kit receptor (MoAb YB5.B8, see above) and
the a-chain of the high af®nity IgE receptor (FcaÊRIa, MoAb 29C6,
kindly provided by Dr. J. Hakimi, Nutley) and by toluidine blue staining
at pH 0.5. Viability of mast cells was over 95%, as determined by trypan
blue staining.
Isolation of human dermal ®broblasts and of
keratinocytes Fibroblasts were obtained from the dermis of juvenile
human foreskin, as described previously (YlaÈ-Outinen et al, 1998).
Brie¯y, the epidermis was enzymatically detached from the dermis by an
overnight incubation with dispase (Boehringer) at a concentration of
1 mg per ml. Dermis was cut into small pieces and incubated in
Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with
antibiotics (streptomycin and penicillin) and 10% FBS. Dermal ®broblasts
grew from these explants within 1 wk. Cells were thereafter trypsinized
and subcultured in the medium described above. Only cells cultured
from passages 2±4 were used for the experiments.
For the isolation of human skin keratinocytes, epidermis obtained
from the procedure described above (isolation of ®broblasts) was used.
The keratinocytes were dispersed from the epidermal sheet by a further
incubation with 0.25% trypsin for 15 min at 37°C. Viability of
keratinocytes was over 95%, as determined by trypan blue staining.
Organotypic cultures Organotypic cultures were done as previously
described (Fusenig, 1994). Collagen gels were composed from 80 vol%
3.8 mg per ml collagen type I from rats' tail (Becton Dickinson,
Heidelberg, Germany) in 0.1% acetic acid, 10 vol% Hanks' solution
(103; with phenol red), and 10 vol% FBS. Cells to be embedded
(®broblasts, 2 3 105 cells per ml; mast cells, 5 3 104 cells per ml) were
diluted in the FBS portion. The pH of the collagen±Hanks' mixture was
adjusted on ice to 7.0 by dropwise addition of NaOH (1 M) prior to
addition of the cells to the gel. The mixture was then poured into
special ®lter-inserts (3 mm pores; Becton Dickinson) and allowed to
solidify during a 1 h incubation at 37°C.
Filter inserts were placed into special 12-well plates (Becton
Dickinson), leaving a reservoir of culture medium underneath. After a 24
h incubation, medium was removed from the inserts and replaced by
0.5 ml of keratinocytes in suspension (1 3 106 cells per ml). After a
further 24 h incubation period, medium was removed from the adherent
keratinocytes, which thereby came into contact with air. This time point
was de®ned as day 1 of organotypic culture. Culture medium, consisting
of FAD Medium (three parts DMEM and one part F12) (Biochrom)
supplemented with adenine (1.8 3 10±4 M), hydrocortisone (0.5 mg per
ml), insulin (5 mg per ml) (all from Sigma, Deisenhofen, Germany),
choleratoxin (10±10 M) (Calbiochem, Schwalbach, Germany), and
epidermal growth factor (EGF) 10 ng per ml (Sigma), was changed every
2 d, leaving the keratinocyte layer exposed to air.
Functionality tests Mast cell function was assessed by histamine
release in response to anti-IgE, using routine methodology, as previously
described (GruÈtzkau et al, 2000). Brie¯y, cocultures were incubated in
1 ml Tyrode's buffer (10 mM HEPES, 130 mM NaCl, 5 mM KCl,
1.4 mM CaCl2, 1 mM MgCl2, 5.6 mM glucose, 0.1% BSA) containing
anti-IgE (Calbiochem-Novabiochem, Bad Soden, Germany) for 30 min
at 37°C and 5%CO2/95% air. Thereafter, histamine content of the
supernatants was determined using a histamine-speci®c EIA kit (Coulter-
Immunotech, Krefeld, Germany).
One criterion for the functionality of keratinocytes within the
organotypic coculture system was their ability to proliferate. The
proliferation index of keratinocytes was tested after 1 and 2 wk of
culture, as previously described (Stark et al, 1999). Brie¯y, cocultures
were incubated with 5-bromodeoxyuridine (BrdU) 10 mM for 24 h.
BrdU incorporation into the replicating cells was detected on cryosec-
tions with a monoclonal antibody (anti-BrdU) after acetone ®xation
(10 min at ±20°C) and 10 min incubation with 2 M HCl at room
temperature, followed by washing in PBS. The number of BrdU-positive
nuclei on the total number of basal cells (3 100%) was used to
determine the BrdU proliferation index. Cells were counted at light
microscopic level (magni®cation 2003) at three different regions in each
section. The resulting data are expressed as the mean of three independ-
ent experiments.
Immunohistology Skin equivalent samples were embedded in
TissueTek (Miles, Diagnostic Division, IN) and frozen in the gas phase
of liquid nitrogen. Cryostat sections (5 mm) of samples were air dried on
glass slides overnight (Super Frost, Menzel-GlaÈser, Heidesheim,
Germany) and ®xed in 100% acetone at ±20°C for 10 min.
For immunohistology, specimens were reincubated in PBS and incu-
bated for 40 min with the following antihuman antibodies: MoAb
anticytokeratin 1, MoAb anticytokeratin 10, MoAb antitransglutaminase
(all from Dianova, Hamburg, Germany), rabbit polyclonal antihuman
anti-involucrin (Paesel-Lorei, Frankfurt, Germany), MoAb anti-BrdU
(Sigma,), MoAb YB5.B8 anti-c-kit receptor (see above), MoAb 29C6
anti-IgE receptor (see above), and MoAb antitryptase (from Dr. A.
Walsh, Southampton, U.K.). In negative control sections, the primary
antibody was substituted by the species-speci®c IgG isotype. After several
washes in PBS, sections were incubated with the respective secondary
antibodies (Dianova) for an additional 45 min at room temperature.
Antibody reactions were visualized by the alkaline phosphate antialkaline
phosphate (APAAP) method using an APAAP complex (DAKO,
Glostrup, Denmark) diluted 1:50 in Tris buffer, as described previously
(Schadendorf et al, 1991). Sections were counterstained with hematox-
ylin.
Electron microscopy Coculture specimens were prepared for electron
microscopy, as described previously (GruÈtzkau et al, 1997). Brie¯y,
cultures were ®xed in 2% glutaraldehyde for 10 min at room
temperature, washed in PBS, and after a graded series of dehydration in
ethanol, 4°C, OsO4 araldite-embedded gels were transferred to araldite
resin and allowed to polymerize for at least 2 d at 60°C. Ultrathin
sections (70 nm) were placed on formvar-coated copper grids and
examined with an EM906 transmission electron microscope at 80 kV
(Zeiss, Oberkochem, Germany).
RESULTS
Estimation of an optimal ratio of mast cells to
®broblasts Initially, we determined the optimal ratio of mast
cells to ®broblasts. For this purpose, mast cells and ®broblasts were
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embedded at varying ratios (1:1, 1:2, 1:4, 1:8) in collagen gels. After
an incubation period of 1 wk, histamine release by mast cells in
response to anti-IgE was measured as a marker of mast cell
functionality (Table I).
Highest levels of histamine release were seen in gels containing
mast cells and ®broblasts at a ratio of 1:2 and 1:4. For further
experiments, we therefore chose a mast cell to ®broblast ratio of
1:4.
Estimation of mast cell functionality and integrity after
long-term culture Human dermal mast cells, cultured for 4 wk
with dermal ®broblasts in collagen gels, as described above, were
activated by anti-IgE in order to induce degranulation. Electron
microscopy revealed that mast cell granules had released their
mediators (picture not shown). Moreover, in activated and
nonactivated mast cells, the formation of cell±cell contacts with
®broblasts was observed (Fig 1).
After 4 wk of culture in ®broblast-containing collagen gels, the
following markers of mast cell integrity were tested: tryptase
(Fig 2), FcaÊRIa, and Kit receptor (data not shown).
Immunohistochemistry revealed positive signals for all markers
tested, indicating that mast cells still express typical features after
long-term culture.
Expression of differentiation markers in skin
equivalents As stated above, the aim of this study was not
only to establish a technique for the long-term culture of mast cells,
but also to study mast cell±keratinocyte interactions in the context
of an organotypic model.
Histologic analysis of skin equivalents containing mast cells and
®broblasts after 2 wk of culture revealed a multilayer epidermis
equivalent that possessed morphologic features similar to those of
normal epidermis (Fig 3), including a basal layer, several suprabasal
layers, and a stratum corneum. In order to assess whether the
keratinocytes in our model undergo differentiation when forming
multilayers, immunostaining with various differentiation markers
was performed. Staining with antibodies directed against cytoker-
atins 1 (Fig 4a) and 10 (Fig 4b) showed positive signals throughout
the suprabasal layers, which resemble their expression pattern in
normal epidermis. A similar staining pattern was obtained using
antibodies directed against transglutaminase, an enzyme essential for
the formation of a corni®ed envelope (Fig 4c).
To estimate whether basal keratinocytes within the skin
equivalents still have the ability to proliferate, incorporation of
BrdU after 1 and 2 wk of culture was determined by anti-BrdU
staining. All positively stained cells were located within the basal
layer. The percentage of positively stained nuclei (in comparison to
Table I. Histamine release from human dermal mast cell











Figure 1. Transmission electron microscopy of mast cell±
®broblast cocultures after 4 wk of culture. Note cell±cell contacts
between mast cells and ®broblasts. Scale bar: 0.5 mm (insert 0.2 mm).
Figure 2. Immunostaining of mast cell tryptase. After a 4 wk
coculture of dermal mast cells and dermal ®broblasts in collagen gels, gels
were stained with a MoAb directed against human mast cell tryptase.
Scale bar: 25 mm.
Figure 3. Immunostaining of mast cell tryptase in skin
equivalents. APAAP staining of skin equivalents using a MoAb directed
against human mast cell tryptase. Vertical cryosection through an
epidermal equivalent maintained 14 d at the air±liquid interface shows
positively stained, functional mast cell. Scale bar: 25 mm.
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the total number of basal cells) was 39% after 1 wk and 19.6% after
2 wk of culture, indicating that the keratinocytes of the basal layer
still had mitogenic activity.
DISCUSSION
This study presents for the ®rst time a model for long-term
coculture of human dermal mast cells with human dermal
®broblasts and human keratinocytes. The model closely approxi-
mates in vivo conditions in that normal mast cells and ®broblasts are
embedded in a collagen gel, whereas keratinocytes are cultured on
the surface of the gel at the air±liquid interface to form an
epidermis-like multilayer.
The ratio of 1:4 (mast cells to ®broblasts) was chosen for routine
studies because histamine release after anti-IgE activation was
practically identical to that with a ratio of 1:2 (Table I). Similar
results have been described before for the coculture of bone-
marrow-derived interleukin-3 independent murine mast cells
(C1MC/C571 cell line) with human dermal ®broblasts
(Yamamoto et al, 2000). Integrity and viability of mast cells after
4 wk of coculture are demonstrated by the expression of mast cell
markers on the cells (tryptase, Kit receptor, FcaÊRIa) as well as by
the demonstration of anti-IgE induced mast cell degranulation.
Another feature of the embedded mast cells is the formation of cell±
cell contacts with the cocultured dermal ®broblasts. A similar
observation has been made during three-dimensional coculture of
leukemic mast cells of the HMC-1 cell line with dermal ®broblasts
(Yamamoto et al, 2000).
The coculture of mast cells with ®broblasts may allow for better
growth and survival of mast cells via production of SCF and nerve
growth factor (Longley et al, 1993; Grabbe et al, 1994; Hogaboam et
al, 1998; Welker et al, 2000), as underlined by the morphologic and
functional integrity of dermal mast cells in our model over a period
of 4 wk despite the lack of externally added growth and survival
factors like SCF, which in monocultures of mast cells are essential
for long-time survival. Differentiating keratinocytes in the skin
equivalent culture may contribute as well because of their known
ability to secrete SCF and nerve growth factor (Pincelli et al, 1994;
Grabbe et al, 1996). Thus, our culture system may also provide a
suitable model for the study of mast cell differentiation and
maturation from their hematopoietic progenitors, which are
recruited from the circulation into the dermis. The speci®c
contribution of mast cells to keratinocyte differentiation and to
®broblast±keratinocyte interaction in this model is of even more
immediate interest because of its relevance to cutaneous physi-
ology. Furthermore, stimulation of mast cells by classical stimuli
like anti-IgE, C5a, and substance P in the context of the model
would add in a major way to the understanding of changes in
various in¯ammatory skin diseases like eczema and psoriasis.
Similarly, stimulation with mediators involved in wound healing
like thrombin may shed further light on the role of mast cells in
tissue repair and ®brosis. Thus, in a culture model using HMC-1
cells instead of dermal mast cells, it has recently been shown that
mast cells induce collagen gel contraction, a process comparable to
physiologic wound contraction (Yamamoto et al, 2000).
Furthermore, the speci®c mast cell mediators tryptase and histamine
as well as mast cell derived growth factors (e.g., platelet-derived
growth factor) can stimulate collagen synthesis by dermal ®broblasts
(reviewed in Artuc et al, 1999). Expansion of the cocultures to
include endothelial cells might provide additional interesting
insights into the process of tissue repair.
Taken together, our paper presents an organotypic coculture
model of human dermal mast cells with dermal ®broblasts and
keratinocytes that may be suitable for the study of cell±cell
interactions in a variety of physiologic (differentiation) and
pathologic (e.g., wound healing, in¯ammation) settings.
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